Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05336032Not ApplicableUnknown

Ethnic Variability in Glycemic and Hunger Satiety Response to Rice in Overweight Adults

Role: lead

NCT04273412Not ApplicableCompleted

Lifestyle Intervention for Prevention of Gestational Diabetes Mellitus in the UAE Population

Role: lead

NCT03644134Not ApplicableCompleted

A Personalized Intervention to Manage Physiological Stress and Improve Sleep Patterns

Role: lead

NCT03388229Completed

Association Between Dietary Pattern and Glycemic Control Among Type 2 Diabetes Patients in the Unites Arab Emirates

Role: lead

NCT02386930Not ApplicableCompleted

Behavioral Lifestyle Intervention Study (BLIS) in Patients With Type 2 Diabetes in UAE: A Randomized Controlled Trial in Real Life Setting

Role: lead

NCT02101151Not ApplicableCompleted

Effect of Vitamin D Supplementation on the Metabolic Control and Body Composition of Type 2 Diabetes Subjects in Ajman (UAE)

Role: lead

All 6 trials loaded